An integrated approach not only leads to better results, but also better value, in both the short- and long-term, according to DarioHealth.   The proliferation of new health-focused smartphone applications has created new opportunities for patients to track and improve their health, but one company argues a less-is-more approach is a better way to help […]

The biopharmaceutical industry is at an all-time high in value, and experts believe it will only continue to become more valuable in the coming years. According to a report from Mordor Intelligence, biopharma companies as a whole are expected to grow around 7% between 2022 and 2027. Not only is this exciting news for those already working in […]

Aristea Therapeutics has dosed the first patient in a phase 2b trial of its palmoplantar pustulosis candidate RIST4721, the company announced in a press release. A CXCR2 antagonist, RIST4721 is in development for the treatment of multiple inflammatory diseases, including the rare chronic skin condition palmoplantar pustulosis (PPP), which is characterized by recurrent sterile pustules on the […]